Consistent with this, NF-κB activation has previously been observed in spinal cord astrocytes in ALS patients as well as in TDP-43 animal models where it was also demonstrated that the inhibition of NF-κB with Withaferin A reduced denervation in neuromuscular junctions 81,82. This evidence concerns the gene NFKB1 and amyotrophic lateral sclerosis.